Acasti Pharma Inc. total revenue, net income and dynamics of changes in Euro today
Acasti Pharma Inc. revenue for the past few reporting periods. Net income Acasti Pharma Inc. - -3 118 000 €. Information about net income is used from open sources. The dynamics of net income of Acasti Pharma Inc. has changed by 2 528 000 € in recent years. Acasti Pharma Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on Acasti Pharma Inc. net income on the chart on this page is drawn in blue bars. The value of the "total revenue of Acasti Pharma Inc." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
0 €
-
-2 915 517.08 €
-
31/03/2021
107 531.90 €
-
-5 279 348.76 €
-
31/12/2020
75 739.86 €
-
-3 010 893.20 €
-
30/09/2020
0 €
-
-5 746 878.76 €
-
31/12/2019
0 €
-
-14 706 623.68 €
-
30/09/2019
0 €
-
-26 502 405.58 €
-
30/06/2019
0 €
-
-10 992 565.36 €
-
31/03/2019
0 €
-
-15 714 618.36 €
-
Show:
to
Acasti Pharma Inc. financial report charts
The dates of the latest financial statements of Acasti Pharma Inc.: 31/03/2019, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Acasti Pharma Inc. is available online for such a date - 30/06/2021. Operating income Acasti Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Acasti Pharma Inc. is -3 145 000 €
Acasti Pharma Inc. quarterly report dates
Net income Acasti Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Acasti Pharma Inc. is -3 118 000 € Current assets Acasti Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Acasti Pharma Inc. is 60 387 000 € Total assets Acasti Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Acasti Pharma Inc. is 60 453 000 €
Current cash Acasti Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Acasti Pharma Inc. is 40 975 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
70 129.50 €
42 077.70 €
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
37 402.40 €
33 662.16 €
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
107 531.90 €
75 739.86 €
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 940 763.70 €
-1 764 458.22 €
-1 836 457.84 €
-2 565 804.64 €
-7 344 896.30 €
-8 083 593.70 €
-8 962 550.10 €
-12 052 923.40 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 915 517.08 €
-5 279 348.76 €
-3 010 893.20 €
-5 746 878.76 €
-14 706 623.68 €
-26 502 405.58 €
-10 992 565.36 €
-15 714 618.36 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
438 543.14 €
423 582.18 €
633 970.68 €
1 202 487.16 €
4 738 884.08 €
4 905 324.76 €
7 685 258.14 €
10 093 972.70 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 940 763.70 €
1 871 990.12 €
1 912 197.70 €
2 565 804.64 €
7 344 896.30 €
8 083 593.70 €
8 962 550.10 €
12 052 923.40 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
56 465 468.22 €
58 321 562.32 €
28 236 941.88 €
12 822 477.78 €
27 687 126.60 €
25 964 746.08 €
26 277 991.18 €
34 906 724.86 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
56 527 182.18 €
58 401 977.48 €
28 335 123.18 €
12 933 749.92 €
36 354 197.74 €
35 382 670.40 €
36 039 082.52 €
45 323 293.26 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
38 314 083.50 €
47 633 826.52 €
24 822 102.76 €
10 801 813.12 €
24 010 470.68 €
24 135 768.72 €
19 562 390.26 €
21 058 486.26 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
13 372 293.06 €
14 374 677.38 €
16 355 134.46 €
17 061 104.76 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
42 132 868.54 €
36 944 220.60 €
32 703 723.50 €
32 267 985.54 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
115.90 %
104.41 %
90.75 %
71.20 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
49 985 502.42 €
52 045 439.60 €
24 045 067.90 €
8 296 787.38 €
-5 778 670.80 €
-1 561 550.20 €
3 335 359.02 €
13 055 307.72 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-8 599 746.82 €
-7 738 556.56 €
-8 564 214.54 €
-9 659 169.80 €
Last revenue report of Acasti Pharma Inc. was 30/06/2021. According to last financial report total revenue in Acasti Pharma Inc. was 0 Euro and changed by 0% since last year. Net income in Acasti Pharma Inc. was -2 915 517.08 € in last quartal, net income changes to 0%.
Acasti Pharma Inc. stocks data
A1PA.F stock price
Acasti Pharma Inc. stock price today, A1PA.F stock quote.
